Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial: Clinical articleNAGAHAMA, Ken; KANAYAMA, Masahiro; TOGAWA, Daisuke et al.Journal of neurosurgery. Spine. 2011, Vol 14, Num 4, pp 500-507, issn 1547-5654, 8 p.Article

BisphosphonatesREID, Ian R.Skeletal radiology. 2007, Vol 36, Num 8, pp 711-714, issn 0364-2348, 4 p.Article

Profiling the safety and tolerability of bisphosphonates : IbandronateBODY, Jean-Jacques; DIEL, Ingo; BELL, Richard et al.Seminars in oncology. 2004, Vol 31, Num 5, pp 73-78, issn 0093-7754, 6 p., SUP10Article

Bisphosphonate actions : Physical chemistry revisitedPAPAPOULOS, Socrates E.Bone (New York, NY). 2006, Vol 38, Num 5, pp 613-616, issn 8756-3282, 4 p.Article

Antitumor Effects and Anticancer Applications of BisphosphonatesMORGAN, Gareth; LIPTON, Allan.Seminars in oncology. 2010, Vol 37, Num 5, issn 0093-7754, S30-S40, SUP2Article

Molecular mechanisms of action of bisphosphonates : Current statusROELOFS, Anke J; THOMPSON, Keith; GORDON, Sharon et al.Clinical cancer research. 2006, Vol 12, Num 20, issn 1078-0432, 6222s-6230s, 2Conference Paper

Design of new arylamino-2-ethane-1,1-diyl- and benzoxazole-2-methylenebisphosphonates vs cytotoxicity and chronic inflammation diseases. From hydrophobicity prediction to synthesis and biological evaluationABDOU, Wafaa M; BARGHASH, Reham F; SEDIEK, Ashraf A et al.European journal of medicinal chemistry. 2012, Vol 57, pp 362-372, issn 0223-5234, 11 p.Article

Les bisphosphonates dans l'ostéoporose cortico-induite: efficacité et toléranceLESPESSAILLES, Eric.Revue du rhumatisme (Ed. française). 2013, Vol 80, Num 2, pp 123-129, issn 1169-8330, 7 p.Article

Osteoclasts play a part in pain due to the inflammation adjacent to boneNAGAE, Maho; HIRAGA, Toru; WAKABAYASHI, Hiroki et al.Bone (New York, NY). 2006, Vol 39, Num 5, pp 1107-1115, issn 8756-3282, 9 p.Article

Une ostéonécrose de la mâchoire = Osteonecrosis of the jawPIERROT-DESEILLIGNY DESPUJOL, C; POUCHOT, J.La Revue de médecine interne (Paris). 2009, Vol 30, Num 8, pp 706-707, issn 0248-8663, 2 p.Article

Bisphosphonate-lnduced osteonecrosis of the jawKRUEGER, Courtney D; WEST, Patricia M; SARGENT, Matthew et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 2, pp 276-284, issn 1060-0280, 9 p.Article

Bisphosphonates and osteonecrosis of the jaw : cause and effect or a Post hoc fallacy?VAN DEN WYNQAERT, T; HUIZING, M. T; VERMORKEN, J. B et al.Annals of oncology. 2006, Vol 17, Num 8, pp 1197-1204, issn 0923-7534, 8 p.Article

Corticoides y osteoporosis = Corticosteroids and osteoporosisGARCIA-BUSTINDUY, M; GANTES, M. A.Actas dermo-sifiliográficas (Ed. impresa). 2007, Vol 98, Num 8, pp 526-530, issn 0001-7310, 5 p.Article

The effects of bisphosphonates on osteoblasts in vitroNAIDU, Aparna; DECHOW, Paul C; SPEARS, Robert et al.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2008, Vol 106, Num 1, pp 5-13, issn 1079-2104, 9 p.Article

Osseointegration of cementless implants with different bisphosphonate regimensEBERHARDT, Christian; STUMPF, Ulla; BRANKAMP, Jochen et al.Clinical orthopaedics and related research. 2006, Num 447, pp 195-200, issn 0009-921X, 6 p.Article

Bisphosphonate-associated mandibular osteonecrosisCARNEIRO, E; VIBHUTE, P; MONTAZEM, A et al.American journal of neuroradiology. 2006, Vol 27, Num 5, pp 1096-1097, issn 0195-6108, 2 p.Article

Pharmaceutical care and community pharmacists' understanding of bisphosphonate dosing informationLI, W. W; KENDLER, D. L.Journal of clinical pharmacy and therapeutics (Print). 2004, Vol 29, Num 6, pp 531-536, issn 0269-4727, 6 p.Article

Les bisphosphonates = BisphosphonatesPETIT, T.La Lettre du sénologue. 2010, Num 48, issn 1289-2505, p. 29Conference Paper

Bisphosphonates and implants : An overviewASPENBERG, Per.Acta orthopaedica (Print). 2009, Vol 80, Num 1, pp 119-123, issn 1745-3674, 5 p.Article

Management of Bisphosphonate Treatment in Clinical PracticeAAPRO, Matti S.Seminars in oncology. 2007, Vol 34, Num 6, issn 0093-7754, S28-S32, SUP4Conference Paper

Long-term outcome of weekly bisphosphonates : OsteoporosisRIZZOLI, René.Clinical orthopaedics and related research. 2006, Num 443, pp 61-65, issn 0009-921X, 5 p.Article

Safety Profile of Intravenous BisphosphonatesMEHROTRA, Bhoomi.Seminars in oncology. 2007, Vol 34, Num 6, issn 0093-7754, S24-S27, SUP4Conference Paper

A biocompatible method of decorporation : Bisphosphonate- modified magnetite nanoparticles to remove uranyl ions from bloodLING WANG; ZHIMOU YANG; JINHAO GAO et al.Journal of the American Chemical Society. 2006, Vol 128, Num 41, pp 13358-13359, issn 0002-7863, 2 p.Article

Targeting systemically administered proteins to bone by bisphosphonate conjugationULUDAG, Hasan; YANG, Jennifer.Biotechnology progress. 2002, Vol 18, Num 3, pp 604-611, issn 8756-7938, 8 p.Article

Les bisphosphonates en oncologie : incertitudes et controverses en 2007 : Cancer = Bisphosphonates in oncology : update 2007ZAMAN, K; FAVET, L; SCHUSTERBAUER, C et al.Revue médicale suisse. 2007, Vol 3, Num 112, issn 1660-9379, 1317-1321 [4 p.]Article